The FDA and CDC recommend getting the new COVID vaccine to fight the new variants spreading this fall. Florida Surgeon ...

Stephane Bancel, Moderna CEO, joins 'Squawk Box' to discuss Moderna's recent stock performance, what could explain the ...

A new COVID variant is raising questions and capturing the attention of researchers heading into the fall and winter season.

The company reported Health Canada authorized the use of its Spikevax KP.2 shot for those aged six months and older. Last ...

The FDA says the latest vaccine formulae "closely targets currently circulating variants" to give better protection against ...

Federal regulators responsible for the safety of the U.S. drug supply are still struggling to get back to where they were in ...

The Food and Drug Administration on Thursday approved the new Covid vaccines from Pfizer and ... started making the new doses in June after the FDA advised them to freshen the formulas to match ...

The protein-based shot represents a non-mRNA option for the 2024-2025 season, and follows the agency's recent approvals and ...

The U.S. Food and Drug Administration (FDA) has approved updated COVID-19 vaccines from Moderna and Pfizer for the 2024-2025 season. The updated mRNA vaccines, Comirnaty and Spikevax, were fully ...

This year’s approval for the updated mRNA vaccines comes much sooner than happened in 2023, when fall vaccines were authorized on Sept. 11. The latest shots from Moderna and Pfizer will now target a ...

"FDA has committed to moving swiftly on regulatory ... health authorities have been working to accelerate this year's rollout of COVID-19 vaccines. Last year's late-September rollout of the ...

U.S. health inspectors are still struggling to address a massive backlog of pharmaceutical plants that went uninspected ...